HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adriano Salaroli Selected Research

Adriano Salaroli Research Topics

Disease

10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016 - 01/2011
4Neoplasms (Cancer)
10/2021 - 01/2020
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2014 - 10/2011
3Infections
01/2021 - 01/2011
3Blast Crisis (Blast Phase)
01/2013 - 06/2011
3Philadelphia Chromosome
01/2013 - 07/2011
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2022 - 10/2013
2Critical Illness (Critically Ill)
10/2021 - 01/2021
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 01/2013
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2013 - 08/2012
2Cytopenia
12/2012 - 08/2012
1Primary Myelofibrosis (Myelosclerosis)
10/2021
1Sepsis (Septicemia)
01/2021
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2021
1Lymphoma (Lymphomas)
01/2020
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2020
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2017
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017
1Anemia
02/2015
1Acute Promyelocytic Leukemia
04/2013
1monosomy Chromosome 7
12/2012
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2012
1Refractory Anemia with Excess of Blasts (RAEM)
08/2012
1Type 2 Diabetes Mellitus (MODY)
04/2012
1Hematologic Neoplasms (Hematological Malignancy)
10/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2011
1Exanthema (Rash)
05/2011
1Opportunistic Infections (Opportunistic Infection)
01/2011
1Virus Diseases (Viral Diseases)
01/2011
1Herpes Zoster
01/2011

Drug/Important Bio-Agent (IBA)

10Imatinib Mesylate (Gleevec)FDA Link
02/2015 - 01/2011
4Azacitidine (5 Azacytidine)FDA Link
10/2013 - 10/2011
3Dasatinib (BMS 354825)FDA Link
01/2013 - 07/2011
2InterferonsIBA
01/2016 - 01/2011
2DeferasiroxFDA Link
01/2014 - 09/2012
2Glucose (Dextrose)FDA LinkGeneric
11/2012 - 04/2012
1glycosylated ferritinIBA
01/2021
1Ferritins (Ferritin)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1CytokinesIBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1CD19 AntigensIBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2017
1Biological ProductsIBA
01/2017
1Interferon-alpha (Interferon Alfa)IBA
01/2016
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2013
1src-Family KinasesIBA
01/2013
1Tyrosine Kinase InhibitorsIBA
01/2013
1MutagensIBA
12/2012
1SolventsIBA
12/2012
1Vincristine (Oncovin)FDA LinkGeneric
12/2012
1Benzene (Benzole)IBA
12/2012
1IronIBA
09/2012
1nilotinibFDA Link
04/2012
1Lenalidomide (CC 5013)FDA Link
05/2011

Therapy/Procedure

6Therapeutics
01/2020 - 01/2011
3Drug Therapy (Chemotherapy)
03/2022 - 10/2011
2Salvage Therapy
10/2013 - 04/2013
1Noninvasive Ventilation
10/2021
1Cell Transplantation
10/2021
1Critical Care (Surgical Intensive Care)
10/2021
1Resuscitation
10/2021
1Cardiopulmonary Resuscitation (CPR)
10/2021
1Artificial Respiration (Mechanical Ventilation)
10/2021
1Immunotherapy
01/2020
1Autologous Transplantation
10/2013
1Radiotherapy
02/2013
1Chelation Therapy (Therapy, Chelation)
09/2012